ZytoLight ® Bladder Cancer Quadruple Color Probe

Description

The ZytoLight ^® Bladder Cancer Quadruple Color Probe is designed to detect CDKN2A (a.k.a. p16) deletions and aneuploidy of chromosomes 3, 7, and 17 in cytology specimens of tumors, e.g., in urine samples from patients with hematuria suspected of having bladder cancer (BC). Moreover, it has been shown that the detection of CDKN2A deletions and/or aneusomies of chromosomes 3, 7, and/or 17 may be used for the surveillance of patients with a history of bladder cancer to early detect possible tumor recurrence.

Ordering Information

Prod. No.:	Tests¹ (Volume):	Registration Status²:
Z-2305-50	5 (50 µl)
Z-2305-200	20 (200 µl)